4. 2. 2025 from 15:00 to 17:00 CET online (via app Zoom)
5 min.
Welcome
G. Teodorescu/L. Mikasova
5 min.
Chairman's introduction
Prof. György Nagy
20 min + 5 min discussion.
The latest advances in the management of SLE - a patient-focused approach
Prof. Marta Mosca
10 min + 5 min discussion.
Romanian Clinical Experience - Efficacy of Anifrolumab on hematological manifestation
Dr. Ioana Saulescu
10 min + 5 min discussion.
Hungarian Clinical Experience
Dr. Tünde Tarr
10 min + 5 min discussion.
Bulgarian Clinical Experience – From Rash to Relief: Anifrolumab’s Efficacy in Lupus Skin Manifestations
Dr. Ivan Goranov
10 min + 5 min discussion.
Polish Clinical Experience - Patient with shrinking lung syndrome treated with anifrolumab
Dr. Agnieszka Glowniak
20 min.
Discussion
All participants
5 min.
Summary and close
G. Teodorescu/L. Mikasova
Registration Form
Disclaimer
This meeting is organized by AstraZeneca Czech Republic s.r.o., ID: 63984482, registered office at U Trezorky 921/2, Jinonice, 158 00 Prague 5, registered in the commercial register maintained by the Municipal Court in Prague, section C, entry 38105 (hereinafter referred to as "AZ").
This meeting is intended exclusively for persons authorized to prescribe or dispense medicinal products in accordance with § 2a of the Act on the Regulation of Advertising. If you are not such a person, please leave this meeting. Participants are not allowed to record this meeting in any way, nor to obtain unauthorized screenshots, photos etc., and share these further.
This meeting may be recorded by AZ. By attending this meeting you express your consent to the acquisition and use of AV recordings and photographs for a period of 10 years in accordance with §84 et seq. of the Civil Code.
Please do not use the chat to report any adverse events, but report them directly to AZ employees.
Expert opinions of the participating physicians are based on their experience to actual date.
The company AZ (administrator of personal data) is authorized to process the following categories of personal data: name, surname, title(s), signature, specialization, or other data that you enter on the attendance sheet. For more information, please visit: http://subjectrequest.astrazeneca.com. Contact the AZ personal data processing officer: Privacy@astrazeneca.com. Purpose of personal data processing: record of the professional event and participants, including record of consent to recording. Legal basis: legitimate interest. Processing method: manual. Potential recipients or categories of recipients of personal data: companies of the AstraZeneca group (https://www.astrazeneca.com/global/en/AstraZeneca-Websites.html), or third parties providing technical support for the information system. Personal data retention period: 10 years.